The family-owned company’s turnover on core brands increased 12.5% year on year, delivering a Group Operating Profit of £138m for 2013, up 10.6% from £124.8m the previous year.

A focus for William Grant & Sons has been innovation, as it launched The Girvan Patent Still and The Kininvie single malts in 2013. The company says it has also continued to invest in its other innovation brands Monkey Shoulder triple malt, Reyka vodka, Solerno Blood Orange liqueur and premium tequila brand Milagro.

The company said Hendrick’s Gin had “phenomenal success” and Glenfiddich continued to “grow rapidly around the world” last year.

Stella David, William Grant & Sons chief executive, said: “Whilst 2013 saw some challenging global economic conditions, the Company continued to perform well thanks to our consistent focus on brand building and investing for the long-term. In short we want to inspire our consumers with our great liquids and the great stories our brands have to tell.”

In December 2013, the Group’s life president and former chairman Charles Grant Gordon died aged 68. David said: “Very few individuals have contributed as much as he has to any one company and to the scotch whisky industry as a whole over such a long time span.”